PCM
EXAS

Portolan Capital Management’s Exact Sciences EXAS Stock Holding History

Portolan Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-141,730
Closed -$2.63M – 128
2016
Q3 		$2.63M Buy
+141,730
New +$2.5M 0.36% 81

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Portolan Capital Management's EXAS Position: Q4 2016 in Review

Portolan Capital Management sold out of Exact Sciences (EXAS) in Q4 2016, closing a stake of 141,730 shares — an estimated $2.63M sold.

Portolan Capital Management first reported a position in EXAS in Q3 2016 and held it in 1 quarter. The position peaked at $2.63M in Q3 2016. 223 funds tracked by Wall St. Rank hold EXAS as of Q4 2016.

  • Portolan Capital Management reported no remaining Exact Sciences position as of Q4 2016 after selling out during the quarter.
  • Portolan Capital Management sold 141,730 Exact Sciences shares in Q4 2016, an estimated $2.63M.
  • Portolan Capital Management first reported a position in Exact Sciences in Q3 2016 and held it in 1 quarter.
  • Portolan Capital Management's Exact Sciences position peaked at $2.63M in Q3 2016.
  • 223 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2016.

Based on Portolan Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.